Press centre

Latest

14 Sep 2021

GARDP Welcomes Funding from Republic and Canton of Geneva to Develop New Gonorrhoea Treatment

GARDP is pleased to announce funding from the Canton of Geneva to support the development of zoliflodacin, a novel antibiotic currently being assessed through a global phase 3 trial for safety and effectiveness as a treatment for gonorrhoea.

1 Sep 2021

GARDP and Thailand’s Ministry of Public Health to Collaborate on Access and Stewardship Plan for New Gonorrhoea Treatment

20 Aug 2021

GARDP calls for nominations for a Board Treasurer

11 Aug 2021

Board seat for Civil Society/patient-centered representation

13 Jul 2021

GARDP, CHAI and Shionogi announce MOU to increase access to antibiotic to treat antimicrobial resistant infections in low- and middle-income countries

9 Jul 2021

GARDP Partners With InfectoPharm To Develop Combination Therapy for Neonatal Sepsis

7 Jun 2021

GARDP Receives Funding From the Government of Japan as Part of Its Ongoing Contribution To Fight Against Drug-Resistant Infections

Media contacts

For media inquiries, please contact the GARDP Communications Department:

Phone: +41 22 555 19 90 | Email: communications@gardp.org

Cookie Policy

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.